JMP Securities analyst Jason Butler maintained a Buy rating on Cytokinetics (CYTK – Research Report) today and set a price target of $78.00.

JMP Securities analyst Reni Benjamin maintained a Buy rating on Blueprint Medicines (BPMC – Research Report) today and set a price target of ...

We recently compiled a list of the 8 AI Stocks on Investors’ Radar. In this article, we are going to take a look at where ...

Mr. Leibel's departure, as stated in the company's SEC filing, is not due to any disagreements or disputes with the company's operations or practices. He will continue to serve as an employee until ...

JMP Securities maintained its Market Perform rating on Apollo Global Management (NYSE:APO) shares without setting a new price ...

Pharvaris (PHVS) is climbing 3% after investment bank JMP Securities raised its price target on the shares to $55, based on ...

Even with its well-documented benefits, DoE is often underutilised, especially for solving specialised or constrained ...

AI is evolving rapidly with recent breakthroughs making it more accessible and efficient than ever. Smaller, cost-effective ...

We recently compiled a list of the 12 AI News Investors Probably Missed. In this article, we are going to take a look at ...

CrowdStrike Holdings was recently the Nasdaq's best-performing stock as it and other cybersecurity companies got a boost after Chinese artificial intelligence startup DeepSeek reported a cyberattack.

We recently compiled a list of the 10 Trending AI Stocks on Wall Street’s Radar. In this article, we are going to take a look ...